| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 2e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |